We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New Imaging Collaboration Could Improve Treatment and Quality of Life of Prostate Cancer Patients

By MedImaging International staff writers
Posted on 27 Jul 2015
Print article
A development agreement between a large medical imaging vendor and smaller medical device company promises to help promote a unique minimally invasive treatment that can ablate the prostate gland.

The agreement will give the device developer access to a large installed base of Magnetic Resonance Imaging (MRI) systems, and customers. The new system can perform minimally invasive, whole gland ablation of the prostate gland in a single session with fewer side effects, and increased quality of life for patients, compared to existing treatments.

The agreement, between Royal Philips (Amsterdam, the Netherlands), and Profound Medical (Toronto, ON, Canada) will help Profound Medical continue to develop its proprietary Transurethral Ultrasound Ablation (TULSA) technology. The TULSA system is designed to work on Philips’ Ingenia and Achieva 3T MRI systems.

The agreement will help Philips continue to expand in the interventional oncology market, using real-time (MRI) 3-D visualization of soft tissue, and industry-leading MRI guided procedure solutions.

Steve Plymale, CEO, of Profound Medical, said, “Philips has stepped forward and enthusiastically shares our vision for the technology. With their support, TULSA-PRO will soon be available to clinicians and patients for primary treatment of localized prostate cancer. This new relationship will provide us with access to a large installed base of MRI systems and customers and we look forward to developing this mutually rewarding relationship further.”

Profound Medical is aiming to obtain the Conformité Européenne (CE) marking and market the TULSA-PRO system in 2016 in Europe and in Canada.

Related Links:

Philips Healthcare
Profound Medical


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Computed Tomography (CT) Scanner
Aquilion Serve SP
MRI System
uMR 588
X-Ray Meter
Cobia SENSE

Print article

Channels

Ultrasound

view channel
Image: Structure of the proposed transparent ultrasound transducer and its optical transmittance (Photo courtesy of POSTECH)

Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis

The ultrasound-photoacoustic dual-modal imaging system combines molecular imaging contrast with ultrasound imaging. It can display molecular and structural details inside the body in real time without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.